NCT04196829

Brief Summary

the main objective of this study is to evaluate staining potential and Caries Arresting Effect of silver diamine fluoride⁄potassium Iodide and silver diamine fluoride in carious anterior primary teeth

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 12, 2019

Completed
21 days until next milestone

Study Start

First participant enrolled

January 2, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

September 10, 2021

Status Verified

September 1, 2021

Enrollment Period

1.6 years

First QC Date

December 8, 2019

Last Update Submit

September 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • staining potential

    change in color of carious lesion using spectrophotometer with unit of measurement percent

    base line and Immediately after material application

Secondary Outcomes (1)

  • caries arresting effect

    3 months, 6 moths, 9 months, 12 months

Other Outcomes (1)

  • post operative pain

    3 months, 6 moths, 9 months, 12 months

Study Arms (2)

silver diamine fluoride ⁄ potassium Iodide

EXPERIMENTAL

38% silver diamine fluoride and a saturated solution of potassium iodide

Drug: silver diamine fluoride ⁄ potassium Iodide

silver diamine fluoride

ACTIVE COMPARATOR

38% silver diamine fluoride

Drug: Silver Diamine Fluoride

Interventions

The affected tooth surface will be gently cleaned and dried with cotton gauze. The gingival tissue of the tooth will be protected with petroleum jelly. An applicator will be dipped into the SDF and 3-4 mg applied to the lesion with microbrush which will be used to paint solution over carious lesion then we will wait for 1 minute till absorption . Then after SDF application KI will be applied using a separate microbrush which will be saturated by the solution and will be used to paint solution over carious lesion , no rinse will be performed and special instructions will be given following application

Also known as: SDF / KI
silver diamine fluoride ⁄ potassium Iodide

The affected tooth surface will be gently cleaned and dried with cotton gauze. The gingival tissue of the tooth will be protected with petroleum jelly. An applicator will be dipped into the SDF and 3-4 mg applied to the lesion with microbrush which will be used to paint solution over carious lesion then we will wait for 1 minute till absorption .

Also known as: SDF
silver diamine fluoride

Eligibility Criteria

Age3 Years - 5 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children with carious primary anterior teeth.
  • Children with no spontaneous pain

You may not qualify if:

  • Tooth mobility
  • Signs of pulpal or periapical infection
  • Severe medical conditions that would not allow management in the clinic
  • Sensitivity to silver or other heavy-metal ions
  • Presence of any gingival or perioral ulceration or stomatitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Egypt

Location

MeSH Terms

Interventions

silver diamine fluoride

Study Officials

  • Mariam Aly, Phd

    Lecturer, Faculty of Dentistry, Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer in pediatric dentistry and dental public health, faculty of dentistry, Cairo university

Study Record Dates

First Submitted

December 8, 2019

First Posted

December 12, 2019

Study Start

January 2, 2020

Primary Completion

August 12, 2021

Study Completion

October 1, 2021

Last Updated

September 10, 2021

Record last verified: 2021-09

Locations